SCHEDULE 13G/A: T. Rowe Price Associates Discloses 8.0% Stake in Revvity Inc.
Beneficial Ownership Report
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.0% of Revvity Inc.'s common stock as of March 31, 2025.
Summary
- T. Rowe Price Associates, Inc., an investment adviser, has filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Revvity Inc.
- As of March 31, 2025, T. Rowe Price Associates, Inc. beneficially owns an aggregate of 9,562,713 shares of Revvity Inc.'s common stock.
- This ownership represents 8.0% of the total class of Revvity Inc. common stock.
- T. Rowe Price Associates, Inc. holds sole voting power over 9,464,460 shares and sole dispositive power over 9,562,679 shares.
- The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment. It simply reports a significant stake.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding Revvity Inc.'s future performance or T. Rowe Price Associates, Inc.'s investment strategy beyond the current ownership disclosure.
Industry Context
This filing reflects a significant institutional investment in Revvity Inc., a company operating in the life sciences and diagnostics industry. Such disclosures are common for large asset managers like T. Rowe Price Associates, Inc., indicating their portfolio positions in publicly traded companies.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake in Revvity Inc., which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 05/14/2025 | Date the Schedule 13G was signed by T. Rowe Price Associates, Inc. |
Keywords
Revvity Inc., T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.